APA (7th ed.) Citation

Yaman, F., Pinar, I. E., Isik, S., Yavasoglu, F., Gunduz, E., Uskudar Teke, H., & Andic, N. (2026). Macrocytosis as an Early Pharmacodynamic Marker of Imatinib Efficacy in Chronic Myeloid Leukemia. Journal of Clinical Medicine, 15(2), 908. https://doi.org/10.3390/jcm15020908

Chicago Style (17th ed.) Citation

Yaman, Fatih, Ibrahim Ethem Pinar, Sevgi Isik, Filiz Yavasoglu, Eren Gunduz, Hava Uskudar Teke, and Neslihan Andic. "Macrocytosis as an Early Pharmacodynamic Marker of Imatinib Efficacy in Chronic Myeloid Leukemia." Journal of Clinical Medicine 15, no. 2 (2026): 908. https://doi.org/10.3390/jcm15020908.

MLA (9th ed.) Citation

Yaman, Fatih, et al. "Macrocytosis as an Early Pharmacodynamic Marker of Imatinib Efficacy in Chronic Myeloid Leukemia." Journal of Clinical Medicine, vol. 15, no. 2, 2026, p. 908, https://doi.org/10.3390/jcm15020908.